We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DISH
1251
DELISTED
DISH Network Corp.
DISH
$3.66M 0.01%
146,418
-24,106
-14% -$757K
CRL icon
1252
Charles River Laboratories
CRL
$13.2B
$3.65M 0.01%
32,265
+1,114
+4% +$139K
TOL icon
1253
Toll Brothers
TOL
$14B
$3.65M 0.01%
110,774
+64,326
+138% +$2.07M
ADC icon
1254
Agree Realty
ADC
$9.22B
$3.65M 0.01%
61,652
+1,137
+2% +$65K
MTZ icon
1255
MasTec
MTZ
$21.5B
$3.64M 0.01%
89,801
-946
-1% -$40.7K
USFR
1256
DELISTED
WisdomTree Bloomberg Floating Rate Treasury Fund
USFR
$3.64M 0.01%
145,202
+135,210
+1,353% +$3.39M
CIEN icon
1257
Ciena
CIEN
$54.9B
$3.63M 0.01%
106,894
+92,185
+627% +$2.92M
TER icon
1258
Teradyne
TER
$57.1B
$3.61M 0.01%
115,074
+10,537
+10% +$357K
LMRK
1259
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$3.61M 0.01%
313,112
-6,822
-2% -$91.6K
CJ
1260
DELISTED
C&J Energy Services, Inc.
CJ
$3.61M 0.01%
267,307
IBDN
1261
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$3.6M 0.01%
148,939
+10,423
+8% +$252K
TREX icon
1262
Trex
TREX
$4.91B
$3.6M 0.01%
121,276
+14,994
+14% +$469K
THD icon
1263
iShares MSCI Thailand ETF
THD
$357M
$3.59M 0.01%
43,313
-12,408
-22% -$1.08M
BAR icon
1264
GraniteShares Gold Shares
BAR
$1.48B
$3.59M 0.01%
280,420
-27,050
-9% -$331K
DCOM icon
1265
Dime Commercial Bancshares
DCOM
$1.77B
$3.59M 0.01%
140,673
-4,426
-3% -$129K
DXJ icon
1266
WisdomTree Japan Hedged Equity Fund
DXJ
$7.43B
$3.58M 0.01%
77,259
-13,495
-15% -$704K
BATRK icon
1267
Atlanta Braves Holdings Series B
BATRK
$3.21B
$3.58M 0.01%
143,735
-3,835
-3% -$97.1K
AGX icon
1268
Argan
AGX
$8.15B
$3.57M 0.01%
94,314
+33,163
+54% +$1.4M
TECH icon
1269
Bio-Techne
TECH
$11.2B
$3.57M 0.01%
98,552
-2,692
-3% -$112K
PWR icon
1270
Quanta Services
PWR
$99.4B
$3.56M 0.01%
118,355
-21,070
-15% -$681K
KRNY icon
1271
Kearny Financial
KRNY
$595M
$3.56M 0.01%
277,515
-23,420
-8% -$305K
COWZ icon
1272
Pacer US Cash Cows 100 ETF
COWZ
$19.6B
$3.55M 0.01%
138,292
+92,002
+199% +$2.59M
PRAH
1273
DELISTED
PRA Health Sciences, Inc.
PRAH
$3.55M 0.01%
38,644
+6,058
+19% +$613K
CW icon
1274
Curtiss-Wright
CW
$25.6B
$3.55M 0.01%
34,764
-10,903
-24% -$1.22M
VTRS icon
1275
Viatris
VTRS
$18.7B
$3.54M 0.01%
129,065
-21,971
-15% -$712K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.